Molecular topology analysis of the differences between drugs, clinical candidate compounds, and bioactive molecules.
about
Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffoldsAn Investigation of the Relationship Between Molecular Topology and CYP3A4 Inhibition for Drug-like Compounds.Disease-Specific Differentiation Between Drugs and Non-Drugs Using Principal Component Analysis of Their Molecular Descriptor Space.The influence of the 'organizational factor' on compound quality in drug discovery.The application of molecular topology for ulcerative colitis drug discovery.
P2860
Molecular topology analysis of the differences between drugs, clinical candidate compounds, and bioactive molecules.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Molecular topology analysis of ...... unds, and bioactive molecules.
@en
Molecular topology analysis of ...... unds, and bioactive molecules.
@nl
type
label
Molecular topology analysis of ...... unds, and bioactive molecules.
@en
Molecular topology analysis of ...... unds, and bioactive molecules.
@nl
prefLabel
Molecular topology analysis of ...... unds, and bioactive molecules.
@en
Molecular topology analysis of ...... unds, and bioactive molecules.
@nl
P356
P1476
Molecular topology analysis of ...... unds, and bioactive molecules.
@en
P2093
Yidong Yang
P304
P356
10.1021/CI1002558
P577
2010-11-15T00:00:00Z